# China Healthcare Business Intelligence Market

> China Healthcare Business Intelligence Market Research Report By Component (Platforms, Software, Service) and By Function (OLAP and Visualization, Performance Management) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 15.22%
- **2024:** $ 202.56 Million
- **2025:** $ 233.39 Million
- **2035:** $ 962.42 Million
- **Key Players:** IBM (US), Oracle (US), SAP (DE), Microsoft (US), Tableau (US), Qlik (US), SAS (US), Informatica (US), Domo (US)

**Report ID:** MRFR/HC/48877-HCR · **Pages:** 200 · **Author:** Vikita Thakur & Rahul Gotadki · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/china-healthcare-business-intelligence-market-50634

---

## Market Summary

## **China Healthcare Business Intelligence Market Overview**

As per MRFR analysis, the China Healthcare Business Intelligence Market Size was estimated at 176.01 (USD Million) in 2023. The China Healthcare Business Intelligence Market Industry is expected to grow from 202.8(USD Million) in 2024 to 1,249.2 (USD Million) by 2035. The China Healthcare Business Intelligence Market CAGR (growth rate) is expected to be around 17.972% during the forecast period (2025 - 2035).

### **Key China Healthcare Business Intelligence Market Trends Highlighted**

The China Healthcare Business Intelligence Market is experiencing significant growth driven by increasing demand for data-driven decision-making in healthcare settings. The government has been actively promoting the digital transformation of the healthcare sector as part of its broader strategy to enhance healthcare quality and efficiency. This push is supported by ongoing investments in information technology and infrastructure, making healthcare systems more interconnected and data-centric.

Furthermore, the growing emphasis on personalized medicine, which relies heavily on data analytics, is propelling the need for advanced healthcare business intelligence solutions.There are numerous opportunities to create predictive analytics tools that can assist in the prevention and management of diseases. In response to the increasing prevalence of chronic diseases in China, healthcare providers are actively seeking insights that will facilitate improved patient outcomes and resource management. 

The integration of artificial intelligence (AI) and machine learning into business intelligence systems provides a means to enhance the capabilities of analytics. Business intelligence can be instrumental in optimising service delivery and comprehending patient behaviours, as is the case with emerging firms in China that concentrate on niche areas such as telemedicine. Healthcare organisations are increasingly investing in cloud-based solutions to improve the accessibility of data and the collaboration of stakeholders, according to recent trends. The significance of rapid response systems has been underscored by the COVID-19 pandemic, which has increased the demand for real-time data access and analytics.

To facilitate a comprehensive understanding of patient health, there is a growing emphasis on the integration of data from a variety of healthcare providers in accordance with national priorities. 

In general, the China Healthcare Business Intelligence Market is poised to undergo a significant transformation as a result of the convergence of government initiatives, market opportunities, and recent developments, thereby fostering a dynamic environment that is conducive to innovation.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **China Healthcare Business Intelligence Market Drivers**

Rising Demand for Data-Driven Decision Making in Healthcare

The increasing demand for data-driven decision making in China is a major driver for the China Healthcare Business Intelligence Market Industry. Healthcare providers are increasingly recognizing the importance of leveraging data analytics for better patient care and operational efficiency. According to the National Health Commission of China, the country aims to integrate artificial intelligence and big data analytics into healthcare services.

This push is anticipated to enhance patient outcomes by at least 30% over the next decade, as organizations like Alibaba Health and Huawei invest in advanced healthcare data solutions.The trend emphasizes the necessity for effective Business Intelligence tools that can analyze vast amounts of patient data and improve strategic decisions, leading to better healthcare services and outcomes nationwide.

Increasing Prevalence of Chronic Diseases

The prevalence of chronic diseases, such as diabetes and cardiovascular diseases, is significantly impacting the China Healthcare Business Intelligence Market Industry. Recent statistics show that approximately 300 million people in China suffer from hypertension, contributing to an annual increase in chronic disease management needs. The Chinese government has recognized this challenge and is enhancing its healthcare infrastructure to better manage such diseases, thereby creating a necessity for advanced business intelligence solutions.Established companies like Siemens Healthineers are investing in technologies to provide actionable insights, enabling healthcare providers to track disease progression efficiently.

The increase in chronic disease cases underscores the urgent need for business intelligence applications in data presentation and analysis.

Government Initiatives and Policies Supporting Healthcare Digitization

Government initiatives aimed at promoting healthcare digitization play a crucial role in the growth of the China Healthcare Business Intelligence Market Industry. The Chinese government has set ambitious goals to digitize healthcare services as part of its 13th Five-Year Plan, which aims to enhance accessibility and quality of care across the nation. Initiatives include substantial funding for health technology startups and partnerships with private sector players.For instance, the recent announcement for a $1 billion investment in health information systems by the Ministry of Finance is likely to drive demand for business intelligence solutions.

This supportive regulatory environment fosters collaboration with leading organizations such as Tencent and Ping An Good Doctor, accelerating the adoption of business intelligence tools across the healthcare sector.

## **China Healthcare Business Intelligence Market Segment Insights**

### **Healthcare Business Intelligence Market Component Insights**

The China Healthcare Business Intelligence Market, particularly the Component segment, encompasses critical areas such as Platforms, Software, and Services, which collectively play a pivotal role in enhancing decision-making processes within the healthcare sector. These components are essential in integrating vast amounts of data generated across healthcare facilities, allowing for improved analytics, reporting, and strategic planning.

Platforms in this segment are increasingly recognized for their ability to facilitate data sharing among healthcare professionals and organizations, which is vital in delivering effective patient care and operational efficiency.Software solutions tailored to the healthcare environment provide analytical capabilities that aid medical practitioners in identifying trends, optimizing operational workflows, and enhancing patient outcomes. 

Meanwhile, Services offered within this segment, including consulting and support, are crucial for the successful implementation and ongoing management of business intelligence initiatives, ensuring that healthcare organizations can adapt quickly to changing regulations and technological advances.

As the healthcare system in China evolves, driven by government policies focusing on improving healthcare delivery and administrative efficiency, the demand for robust components in business intelligence continues to grow, fostering innovations that enhance data usability and strategic insights.This growing emphasis on integrating comprehensive data analytics tools into healthcare strategies aligns with the increasing need for evidence-based decision-making, providing significant opportunities for stakeholders in the market as they seek to meet the rising expectations of both healthcare providers and patients. 

The continuous investment in health information technologies and business intelligence is further propelled by the need for improved patient outcomes and operational efficiencies, as well as the growing volume of healthcare data generated annually in China.Overall, the Component segment remains fundamental in transforming how healthcare services are delivered, driving particular advancement in Platforms and Software that empower healthcare providers to make informed decisions swiftly and efficiently, thus catering effectively to the needs of patients and the healthcare system at large.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Healthcare Business Intelligence Market Function Insights**

The Function segment of the China Healthcare Business Intelligence Market plays a pivotal role, contributing to the sector's dynamic growth and transformation. The market shows a significant inclination towards advanced analytics capabilities, with OLAP (Online Analytical Processing) and Visualization being crucial components. OLAP enables healthcare organizations to perform multidimensional analysis of data, which is essential for decision-making in clinical and operational settings.

Visualization tools enhance data interpretation, allowing stakeholders to glean insights rapidly from complex datasets, thus improving patient outcomes and operational efficiency.Performance Management is another vital aspect, aiding in tracking key performance indicators (KPIs) and ensuring that healthcare entities align with regulatory standards. 

The increasing emphasis on data-driven strategies within the Chinese healthcare system is steering enhancements in these areas. As healthcare facilities strive for excellence in service delivery and operational effectiveness, the integration of these functions becomes paramount, driving the overall market growth. Moreover, with the rise of digital health initiatives and government support towards healthcare digitization, there are profound opportunities for development and implementation of these analytical functions, ultimately leading to enhanced care quality and patient satisfaction in the rapidly evolving Chinese healthcare landscape.

## **China Healthcare Business Intelligence Market Key Players and Competitive Insights**

The competitive insights of the China Healthcare Business Intelligence Market reveal a rapidly evolving landscape characterized by growing demand for advanced analytics, data-driven decision-making, and innovative solutions tailored to the unique healthcare challenges in the region. The market has seen an influx of domestic and international firms striving to establish their footprint by leveraging technology to improve patient outcomes, streamline operations, and support regulatory compliance. As healthcare providers increasingly adopt digital health systems and electronic health records, the need for sophisticated business intelligence tools becomes paramount.

This ongoing transformation presents opportunities for existing players to enhance their market presence and for newcomers to gain traction, fostering a competitive dynamic that can drive innovation and investment.

Cerner holds a notable position within the China Healthcare Business Intelligence Market, leveraging its extensive expertise in health information technology to offer comprehensive solutions that appeal to local healthcare providers. Cerner's strengths lie in its robust data analytics capabilities, which enable hospitals and healthcare systems to improve clinical and operational efficiencies. The company’s emphasis on integrating its platforms with existing health information systems in China allows for seamless adoption and maximizes benefits for users.

By focusing on building strong relationships with local healthcare stakeholders, Cerner has established a solid market presence, ensuring that its solutions are aligned with the needs of healthcare professionals and the goals of health policymakers in the region.Optum is another significant player in the China Healthcare Business Intelligence Market, offering a wide range of services aimed at enhancing healthcare delivery and outcomes. 

The company's key products include analytics and technology solutions that empower healthcare organizations to derive actionable insights from large volumes of health data. Optum’s market presence is bolstered by its strong partnerships with various healthcare providers and payers in China, as well as its commitment to leveraging data to drive value-based care models. The organization has also made strategic investments and acquisitions to fortify its position within the market, enabling it to offer integrated solutions that encompass population health management, pharmacy care services, and care delivery optimization.

With a focus on collaboration and innovation, Optum continues to play a vital role in shaping the future of healthcare analytics in China, tailoring its offerings to meet the unique demands of the local market.

**Key Companies in the China Healthcare Business Intelligence Market Include**

## **China Healthcare Business Intelligence Market Industry Developments**

In recent developments within the China Healthcare Business Intelligence Market, several notable advancements have emerged. Notably, in October 2023, Siemens Healthineers announced its collaboration with leading hospitals in China to enhance diagnostic imaging solutions, aiming to improve patient care through advanced analytics. Additionally, in September 2023, IQVIA launched a new platform focused on real-time data insights for healthcare providers, which has gained significant traction among Chinese healthcare organizations. In the context of mergers and acquisitions, in August 2023, UnitedHealth Group completed the acquisition of a local telehealth company, boosting its footprint in China's digital healthcare space. 

The market has witnessed substantial growth, with a valuation increase driven by rising demand for data-driven decision-making tools among healthcare practitioners and hospitals. Over the past few years, significant activities include Roche Diagnostics opening a state-of-the-art laboratory in Shanghai in June 2022 to enhance its diagnostic capabilities. This environment fosters innovation, as companies like Cerner and EPIC Systems are increasingly interested in establishing local partnerships, emphasizing the competitive landscape of the healthcare intelligence sector in China. The continuous evolution of healthcare policies further accentuates the need for advanced business intelligence solutions in the market.

## **China Healthcare Business Intelligence Market Segmentation Insights**

### **Healthcare Business Intelligence Market Component Outlook**

### **Healthcare Business Intelligence Market Function Outlook**

## Market Drivers

### Emergence of Telehealth Services

The emergence of telehealth services in China is reshaping the healthcare landscape and driving the healthcare business-intelligence market. As telehealth becomes more prevalent, healthcare providers are increasingly relying on data analytics to monitor patient outcomes and optimize virtual care delivery. Business-intelligence solutions play a vital role in analyzing telehealth data, enabling providers to assess the effectiveness of remote consultations and treatments. This trend is likely to accelerate as more patients seek convenient healthcare options, leading to a projected increase in telehealth adoption by 30% over the next few years. The integration of business-intelligence tools within telehealth services is expected to enhance patient engagement and satisfaction, thereby propelling the growth of the healthcare business-intelligence market in China.

### Increasing Focus on Patient-Centric Care

The shift towards patient-centric care in China is emerging as a pivotal driver for the healthcare business-intelligence market. Healthcare providers are increasingly recognizing the importance of tailoring services to meet individual patient needs, which necessitates the use of advanced analytics. Business-intelligence solutions enable healthcare organizations to analyze patient data, identify trends, and personalize treatment plans. This focus on patient outcomes is likely to drive investments in business-intelligence tools that enhance the understanding of patient preferences and behaviors. As a result, the healthcare business-intelligence market is expected to witness robust growth, with organizations seeking to leverage data analytics to improve patient satisfaction and engagement. The emphasis on patient-centric approaches aligns with broader healthcare reforms in China, further propelling the demand for business-intelligence solutions.

### Regulatory Support for Health IT Initiatives

In China, the government is actively promoting health information technology (IT) initiatives, which significantly impacts the healthcare business-intelligence market. Regulatory frameworks are being established to encourage the adoption of digital health solutions, including business-intelligence tools. The Chinese government has allocated substantial funding to support the development of health IT infrastructure, aiming to improve healthcare quality and accessibility. This regulatory support is expected to enhance the integration of business-intelligence solutions within healthcare organizations, facilitating better data management and analytics capabilities. As a result, healthcare providers are likely to adopt these technologies more readily, contributing to the overall growth of the healthcare business-intelligence market. The alignment of government policies with industry needs creates a conducive environment for innovation and investment in health IT.

### Growing Demand for Data-Driven Decision Making

The healthcare business-intelligence market in China is experiencing a notable surge in demand for data-driven decision-making processes. As healthcare providers increasingly recognize the value of data analytics, they are investing in advanced business-intelligence solutions to enhance operational efficiency and patient outcomes. Reports indicate that the market is projected to grow at a CAGR of approximately 15% over the next five years. This growth is driven by the need for real-time insights into patient care, resource allocation, and treatment effectiveness. Consequently, healthcare organizations are prioritizing the implementation of business-intelligence tools that facilitate data analysis and visualization, thereby enabling informed decision-making. The emphasis on data-driven strategies is likely to reshape the landscape of healthcare delivery in China, making it a critical driver for the healthcare business-intelligence market.

### Rising Investment in Healthcare Infrastructure

China's ongoing investment in healthcare infrastructure is significantly influencing the healthcare business-intelligence market. The government has committed to enhancing healthcare facilities and services, which includes the integration of advanced technologies. As hospitals and clinics upgrade their infrastructure, there is a growing need for business-intelligence solutions to manage and analyze the vast amounts of data generated. This investment is projected to reach approximately $200 billion by 2026, creating a favorable environment for the adoption of business-intelligence tools. Healthcare organizations are likely to seek solutions that can streamline operations, improve patient care, and optimize resource utilization. Consequently, the rising investment in healthcare infrastructure serves as a crucial driver for the healthcare business-intelligence market, fostering innovation and technological advancement.

## Future Outlook

The [Healthcare Business Intelligence Market](https://www.marketresearchfuture.com/reports/healthcare-business-intelligence-market-7544) in China is poised for growth at a 15.22% CAGR from 2025 to 2035, driven by technological advancements and increasing data utilization.

**New opportunities:**

- Development of AI-driven predictive analytics tools for patient outcomes.
- Integration of real-time data dashboards for healthcare providers.
- Expansion of cloud-based BI solutions tailored for healthcare organizations.

By 2035, the market is expected to achieve substantial growth, reflecting its critical role in healthcare innovation.

## Segment Insights

### By Component: Software (Largest) vs. Platforms (Fastest-Growing)

In the China healthcare business-intelligence market, the distribution of market share among the component segments reveals that Software holds the largest share, catering extensively to healthcare providers seeking comprehensive data solutions. Platforms follow closely, gaining traction due to their ability to integrate multiple data sources into cohesive systems for better decision-making. These trends indicate a growing preference for integrated solutions among healthcare organizations that aim to enhance operational efficiency.

The growth trends in this segment are driven by the increasing demand for data analytics and management tools that can streamline healthcare operations. As digital transformation continues in the healthcare sector, platforms are emerging as the fastest-growing option due to their scalability and flexibility. Innovations in AI and machine learning are also propelling platforms forward, as they enable predictive analytics and real-time data processing, thus enhancing the overall functionality of healthcare services.

Software (Dominant) vs. Platforms (Emerging)

Software remains the dominant force in the China healthcare business-intelligence market, primarily because it provides robust, feature-rich solutions designed specifically for healthcare applications. Its extensive capabilities support various functions ranging from patient management to sophisticated analytical tools. On the other hand, Platforms are seen as an emerging player, gaining momentum due to their ability to offer integrated solutions that connect disparate data sources. Their flexibility makes them particularly appealing to healthcare providers looking to adapt to evolving technology landscapes. As both Software and Platforms continue to evolve, their collaborative potential could redefine healthcare intelligence, enhancing overall efficiency and effectiveness in healthcare delivery.

### By Function: OLAP and Visualization (Largest) vs. Performance Management (Fastest-Growing)

In the China healthcare business-intelligence market, the market share distribution highlights OLAP and Visualization as the dominant segment. This segment serves as a critical tool for data analytics and reporting, allowing healthcare professionals to derive actionable insights from complex datasets. On the other hand, Performance Management is emerging rapidly, focusing on optimizing operational efficiency and enhancing clinical decision-making through advanced metrics and analysis.

The growth trends for these segments are driven by the increasing need for data-driven decision-making in healthcare. The rising adoption of digital health solutions further propels the demand for OLAP and Visualization tools, as they provide comprehensive data handling capabilities. Meanwhile, Performance Management's rapid growth can be attributed to the emphasis on improving patient outcomes and streamlining healthcare operations, making it a key area of investment for organizations aiming for operational excellence.

OLAP and Visualization (Dominant) vs. Performance Management (Emerging)

OLAP and Visualization dominate the segment with their robust capabilities in handling vast amounts of data, transforming it into visual formats that enhance understanding and decision-making. They are instrumental for healthcare institutions aiming to improve clinical performance and patient care through insightful data visualization. In contrast, Performance Management is carving out its place as an emerging necessity, focusing on analyzing the effectiveness of healthcare delivery systems. This segment is pivotal for organizations looking to enhance efficiency and accountability by leveraging data analytics to refine workflows and measure quality outcomes. The intersection of these two segments highlights the evolving landscape of healthcare analytics, where integrated solutions are becoming increasingly valuable.

## Competitive Benchmarking

The healthcare business-intelligence market in China is characterized by a rapidly evolving competitive landscape, driven by technological advancements and increasing demand for data-driven decision-making. Key players such as IBM (US), Oracle (US), and SAP (DE) are strategically positioned to leverage their extensive portfolios in analytics and cloud computing. These companies focus on innovation and partnerships to enhance their offerings, thereby shaping a competitive environment that emphasizes agility and responsiveness to market needs. The collective strategies of these firms indicate a trend towards integrated solutions that combine data analytics with operational efficiency, catering to the unique requirements of the healthcare sector.In terms of business tactics, companies are increasingly localizing their operations to better serve the Chinese market. This includes optimizing supply chains and establishing regional partnerships to enhance service delivery. The market appears moderately fragmented, with several players vying for dominance, yet the influence of major companies remains substantial. Their ability to innovate and adapt to local regulations and consumer preferences is crucial in maintaining competitive advantage.

In October  IBM (US) announced a partnership with a leading Chinese healthcare provider to develop AI-driven analytics tools aimed at improving patient outcomes. This strategic move underscores IBM's commitment to integrating advanced technologies into healthcare solutions, potentially enhancing its market share in a rapidly growing sector. The collaboration is expected to facilitate the development of tailored solutions that address specific healthcare challenges in China, thereby reinforcing IBM's position as a leader in healthcare business intelligence.Similarly, in September 2025, Oracle (US) launched a new cloud-based platform designed specifically for healthcare organizations in China. This platform aims to streamline data management and enhance interoperability among various healthcare systems. The introduction of this platform reflects Oracle's strategy to capitalize on the increasing demand for cloud solutions in the healthcare sector, positioning the company to capture a larger share of the market as organizations seek to modernize their IT infrastructures.

In August  SAP (DE) expanded its operations in China by establishing a dedicated healthcare division focused on providing analytics solutions tailored to local needs. This strategic expansion indicates SAP's recognition of the unique challenges faced by the Chinese healthcare system and its commitment to delivering customized solutions. By aligning its offerings with local market demands, SAP is likely to strengthen its competitive position and foster long-term relationships with healthcare providers.

As of November  the competitive trends in the healthcare business-intelligence market are increasingly defined by digitalization, AI integration, and a focus on sustainability. Strategic alliances among key players are shaping the landscape, fostering innovation and enhancing service delivery. The shift from price-based competition to a focus on technological advancement and supply chain reliability is evident, suggesting that future competitive differentiation will hinge on the ability to innovate and adapt to the evolving needs of the healthcare sector.

## Recent News & Developments

In recent developments within the China Healthcare Business Intelligence Market, several notable advancements have emerged. Notably, in October 2023, Siemens Healthineers announced its collaboration with leading hospitals in China to enhance diagnostic imaging solutions, aiming to improve patient care through advanced analytics. Additionally, in September 2023, IQVIA launched a new platform focused on real-time data insights for healthcare providers, which has gained significant traction among Chinese healthcare organizations. In the context of mergers and acquisitions, in August 2023, UnitedHealth Group completed the acquisition of a local telehealth company, boosting its footprint in China's digital healthcare space. 

The market has witnessed substantial growth, with a valuation increase driven by rising demand for data-driven decision-making tools among healthcare practitioners and hospitals. Over the past few years, significant activities include Roche Diagnostics opening a state-of-the-art laboratory in Shanghai in June 2022 to enhance its diagnostic capabilities. This environment fosters innovation, as companies like Cerner and EPIC Systems are increasingly interested in establishing local partnerships, emphasizing the competitive landscape of the healthcare intelligence sector in China. The continuous evolution of healthcare policies further accentuates the need for advanced business intelligence solutions in the market.

## Report Scope

| MARKET SIZE 2024 | 202.56(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 233.39(USD Million) |
| MARKET SIZE 2035 | 962.42(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 15.22% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | IBM (US), Oracle (US), SAP (DE), Microsoft (US), Tableau (US), Qlik (US), SAS (US), Informatica (US), Domo (US) |
| Segments Covered | Component, Function |
| Key Market Opportunities | Integration of advanced analytics and artificial intelligence enhances decision-making in the healthcare business-intelligence market. |
| Key Market Dynamics | Rising demand for data analytics in healthcare drives innovation and competition in the healthcare business-intelligence market. |
| Countries Covered | China |

## Frequently Asked Questions

**Q: What was the market valuation of the China healthcare business-intelligence market in 2024?**
A: The market valuation was $202.56 Million in 2024.

**Q: What is the projected market valuation for the China healthcare business-intelligence market in 2035?**
A: The projected valuation for 2035 is $962.42 Million.

**Q: What is the expected CAGR for the China healthcare business-intelligence market during the forecast period 2025 - 2035?**
A: The expected CAGR is 15.22% during the forecast period 2025 - 2035.

**Q: Which companies are considered key players in the China healthcare business-intelligence market?**
A: Key players include IBM, Oracle, SAP, Microsoft, Tableau, Qlik, SAS, Informatica, and Domo.

**Q: What were the segment valuations for platforms in the China healthcare business-intelligence market?**
A: The segment valuation for platforms was $40.51 Million to $186.0 Million.

**Q: What were the segment valuations for software in the China healthcare business-intelligence market?**
A: The segment valuation for software ranged from $85.12 Million to $400.0 Million.

**Q: What were the segment valuations for services in the China healthcare business-intelligence market?**
A: The segment valuation for services was $76.93 Million to $376.42 Million.

**Q: What were the segment valuations for OLAP and visualization functions?**
A: The segment valuation for OLAP and visualization was $80.64 Million to $368.97 Million.

**Q: What were the segment valuations for performance management functions?**
A: The segment valuation for performance management was $121.92 Million to $593.45 Million.

**Q: How does the growth of the China healthcare business-intelligence market compare to its valuation in 2024?**
A: The market is expected to grow significantly from $202.56 Million in 2024 to $962.42 Million by 2035.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/china-healthcare-business-intelligence-market-50634*